NASDAQ:CUTR • US2321091082
The current stock price of CUTR is 0.0969 USD. Today CUTR is down by -10.19%. In the past month the price decreased by -76.55%. In the past year, price decreased by -95.13%.
ChartMill assigns a technical rating of 0 / 10 to CUTR. When comparing the yearly performance of all stocks, CUTR is a bad performer in the overall market: 99.29% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to CUTR. CUTR has a bad profitability rating. Also its financial health evaluation is rather negative.
On February 19, 2025 CUTR reported an EPS of -1.67 and a revenue of 32.50M. The company missed EPS expectations (-70.55% surprise) and missed revenue expectations (-0.69% surprise).
9 analysts have analysed CUTR and the average price target is 2.04 USD. This implies a price increase of 2005.26% is expected in the next year compared to the current price of 0.0969.
For the next year, analysts expect an EPS growth of -15.64% and a revenue growth -32.88% for CUTR
Over the last trailing twelve months CUTR reported a non-GAAP Earnings per Share(EPS) of -4.92. The EPS decreased by -53.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -61.31% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.08 | 193.084B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.96 | 176.393B | ||
| SYK | STRYKER CORP | 24.11 | 141.687B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.37 | 108.246B | ||
| IDXX | IDEXX LABORATORIES INC | 41.06 | 49.421B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.46 | 48.681B | ||
| BDX | BECTON DICKINSON AND CO | 10.61 | 48.418B | ||
| RMD | RESMED INC | 20.59 | 37.195B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.79 | 35.143B | ||
| DXCM | DEXCOM INC | 26.97 | 27.57B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.99 | 18.52B | ||
| PODD | INSULET CORP | 37.39 | 16.95B | ||
| HOLX | HOLOGIC INC | 15.05 | 16.91B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Cutera, Inc. engages in the provision of laser and energy-based aesthetic systems for practitioners. The company is headquartered in Brisbane California, California and currently employs 430 full-time employees. The company went IPO on 2004-03-31. The firm develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The firm distributes third-party manufactured Secret systems and consumables. The company markets various system platforms, such as AviClear, enlighten, excel V/V+, excel HR, truSculpt, Secret PRO, Secret DUO Secret RF, xeo, and xeo+, each of which enables medical practitioners to perform procedures, including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions. With its xeo platform, practitioners can purchase customized systems with a variety of the Company’s multi-technology applications. Each of the Company’s products consists of a control console and one or more hand pieces, depending on the model.
CUTERA INC
3240 Bayshore Blvd
Brisbane California CALIFORNIA 94005 US
CEO: David H. Mowry
Employees: 430
Phone: 14156575500
Cutera, Inc. engages in the provision of laser and energy-based aesthetic systems for practitioners. The company is headquartered in Brisbane California, California and currently employs 430 full-time employees. The company went IPO on 2004-03-31. The firm develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The firm distributes third-party manufactured Secret systems and consumables. The company markets various system platforms, such as AviClear, enlighten, excel V/V+, excel HR, truSculpt, Secret PRO, Secret DUO Secret RF, xeo, and xeo+, each of which enables medical practitioners to perform procedures, including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions. With its xeo platform, practitioners can purchase customized systems with a variety of the Company’s multi-technology applications. Each of the Company’s products consists of a control console and one or more hand pieces, depending on the model.
The current stock price of CUTR is 0.0969 USD. The price decreased by -10.19% in the last trading session.
CUTR does not pay a dividend.
CUTR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
CUTR stock is listed on the Nasdaq exchange.
9 analysts have analysed CUTR and the average price target is 2.04 USD. This implies a price increase of 2005.26% is expected in the next year compared to the current price of 0.0969.